Anti-mag Neuropathy
📧 Sign up to get email alerts when something new happens for Anti-mag Neuropathy.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-11-24Clinical Trial Update: Rituximab Therapy in Anti-Myelin Associated Glycoprotein Patients With Characteristics of Good Responders [Phase 3]
A Phase 3 clinical trial evaluating rituximab therapy for anti-MAG neuropathy is currently recruiting.
-
CLINICAL_TRIALS research · 2025-04-08Clinical Trial Update: Zanubrutinib Treatment in Patients With IgM Monoclonal Gammopathy and Antri-MAG Related Polyneuropathy [Phase 2]
A Phase 2 clinical trial investigating zanubrutinib for IgM monoclonal gammopathy with anti-MAG-related polyneuropathy is currently recruiti…
-
CLINICAL_TRIALS trial_result · 2025-01-27Clinical Trial Update: Quantification of Nerve Stiffness in Neuropathies [NA]
A completed clinical trial update investigating quantification of nerve stiffness in inflammatory neuropathies including Chronic Inflammator…
-
CLINICAL_TRIALS trial_result · 2024-09-27Clinical Trial Update: Lenalidomide in Anti-MAG Neuropathy: Phase 1b Study [Phase 1]
A Phase 1b trial evaluating lenalidomide for Anti-MAG neuropathy has been terminated.
-
CLINICAL_TRIALS trial_result · 2020-11-02Clinical Trial Update: SERENDEM : MD1003 in Patients Suffering From Demyelinating Neuropathies, an Open Label Pilot Study [Phase 2]
Phase 2 open-label pilot study of MD1003 (serendem) in demyelinating neuropathies completed with results posted.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.